dc.contributorCaviedes Gonzalez, José Gabriel
dc.creatorPierotty Carvajal, Mathieu
dc.creatorTrujillo Calderón, Nasly Stephanie
dc.creatorCárdenas, Vanessa
dc.creatorCaviedes Gonzalez, Jose Gabriel
dc.creatorForero Melo, Julian Francisco
dc.creatorRoa Benavides, Jose Luis
dc.creatorPérez Hidalgo, Juan Manuel
dc.date.accessioned2016-08-30T20:03:04Z
dc.date.available2016-08-30T20:03:04Z
dc.date.created2016-08-30T20:03:04Z
dc.date.issued2016
dc.identifierhttp://repository.urosario.edu.co/handle/10336/12317
dc.identifierhttps://doi.org/10.48713/10336_12317
dc.description.abstractThe transjugular intrahepatic portosystemic shunt (TIPS) is an important technique in the management of complications of portal hypertension, especially in patients candidates for liver transplantation. This an analytical observational study, without risk, in which methods and techniques of retrospective documentary research were used, and no type of intervention was conducted on the physiological, psychological and social variables of the population included. We described patient demographic, clinical features, imaging findings and associated fetures with the procedure of patients whith portal hypertension who have been handled with TIPS at Fundación Cardioinfantil, in Bogotá, Colombia, since January 1, 2007 to June 30, 2016. 54 patients where included , of which 66.7% had no immediate complications, taken into account since the end of the procedure and up to 24 hours after; however, they made their debut with encephalopathy 16.9% during this period. As to late complications, the most frequent was ascites with 66.7%, with a mortality of 20.4% of which 45% of these were secondary to septic shock and organ failure. Although the percentage of complications associated with the procedure was high in our patients, is within the values reported in the literature. The results presented are a starting point for the evaluation of the procedure in our population and enable to implement improvement strategies that lead to impact positively on the rate of complications and mortality derived from the procedure.
dc.languagespa
dc.publisherUniversidad del Rosario
dc.publisherEspecialización en Radiología
dc.publisherFacultad de Medicina
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAbierto (Texto completo)
dc.rightsAtribución-NoComercial-SinDerivadas 2.5 Colombia
dc.rightsEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.
dc.sourceCichoz-Lach H, Celinski K, Slomka M, Kasztelan-Szczerbinska B. Pathophysiology of portal hypertension. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society. 2008;59 Suppl 2:231-8.
dc.sourceSass DA, Chopra KB. Portal Hypertension and Variceal Hemorrhage. Medical Clinics of North America. 2009;93(4):837-53.
dc.sourceBoyer TD. Transjugular intrahepatic portosystemic shunt: current status. Gastroenterology. 2003;124(6):1700-10.
dc.sourceToubia N, Sanyal AJ. Portal Hypertension and Variceal Hemorrhage. Medical Clinics of North America. 2008;92(3):551-74.
dc.sourceJaffe DL, Chung RT, Friedman LS. MANAGEMENT OF PORTAL HYPERTENSION AND ITS COMPLICATIONS. Medical Clinics of North America. 1996;80(5):1021-34.
dc.sourceColombato L. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension. Journal of clinical gastroenterology. 2007;41 Suppl 3:S344-51.
dc.sourceGronbaek H, Astrup LB, Nielsen DT, Vilstrup H. [Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of complications of portal hypertension in patients with liver cirrhosis]. Ugeskrift for laeger. 2003;165(5):439-42.
dc.sourceKhanna R, Sarin SK. Non-cirrhotic portal hypertension - diagnosis and management. Journal of hepatology. 2014;60(2):421-41.
dc.sourceGupta TK, Chen L, Groszmann RJ. Pathophysiology of portal hypertension. Clinics in liver disease. 1997;1(1):1-12.
dc.sourceKirby JM, Cho KJ, Midia M. Image-guided intervention in management of complications of portal hypertension: more than TIPS for success. Radiographics : a review publication of the Radiological Society of North America, Inc. 2013;33(5):1473-96.
dc.sourceSmith JL, Graham DY. Variceal hemorrhage: a critical evaluation of survival analysis. Gastroenterology. 1982;82(5 Pt 1):968-73.
dc.sourcede Franchis R, Primignani M. Why do varices bleed? Gastroenterology clinics of North America. 1992;21(1):85-101.
dc.sourceKrige JE, Bornman PC, Goldberg PA, Terblanche J. Variceal rebleeding and recurrence after endoscopic injection sclerotherapy: a prospective evaluation in 204 patients. Archives of surgery (Chicago, Ill : 1960). 2000;135(11):1315-22.
dc.sourceCopelan A, Kapoor B, Sands M. Transjugular intrahepatic portosystemic shunt: indications, contraindications, and patient work-up. Seminars in interventional radiology. 2014;31(3):235-42.
dc.sourceBilbao JI, Quiroga J, Herrero JI, Benito A. Transjugular intrahepatic portosystemic shunt (TIPS): current status and future possibilities. Cardiovasc Intervent Radiol. 2002;25(4):251-69.
dc.sourceRuiz-Blard E, Baiges A, Turon F, Hernández-Gea V, García-Pagán JC. [Early Transjugular intrahepatic portosystemic shunt: When, how and in whom?]. Gastroenterol Hepatol. 2015.
dc.sourceCarreiro G, Moreira AL, Murad FF, Azevedo F, Coelho HS. [TIPS - Transjugular intrahepatic portosystemic shunt. A review]. Arquivos de gastroenterologia. 2001;38(1):69-80.
dc.sourceMauro M, Murphy KPJ, Thomson KR, Venbrux AC, Morgan RA. Trasnyugular Intrahepatic Portosystemic Shunt. In: Elsevier, editor. Imaged-guide Interventions. Second ed: Elsevier; 2014. p. 822-8.
dc.sourcePapatheodoridis GV, Goulis J, Leandro G, Patch D, Burroughs AK. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis. Hepatology. 1999;30(3):612-22.
dc.sourceFerguson JW, Hayes PC. Transjugular intrahepatic portosystemic shunt in the prevention of rebleeding in oesophageal varices. European journal of gastroenterology & hepatology. 2006;18(11):1167-71.
dc.sourceGarcía-Pagán JC, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362(25):2370-9.
dc.sourceDitah IC, Al Bawardy BF, Saberi B, Ditah C, Kamath PS. Transjugular intrahepatic portosystemic stent shunt for medically refractory hepatic hydrothorax: A systematic review and cumulative meta-analysis. World journal of hepatology. 2015;7(13):1797-806. 24. Masson S, Mardini HA, Rose JD, Record CO. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience. QJM. 2008;101(6):493-501.
dc.sourceStanley AJ, Jalan R, Forrest EH, Redhead DN, Hayes PC. Longterm follow up of transjugular intrahepatic portosystemic stent shunt (TIPSS) for the treatment of portal hypertension: results in 130 patients. Gut. 1996;39(3):479-85.
dc.sourceSaravanan R, Nayar M, Gilmore IT, Smart H, McWilliams RG, Rowlands PC, et al. Transjugular intrahepatic portosystemic stent shunt: 11 years' experience at a regional referral centre. European journal of gastroenterology & hepatology. 2005;17(11):1165-71.
dc.sourceDeltenre P, Trepo E, Rudler M, Monescillo A, Fraga M, Denys A, et al. Early transjugular intrahepatic portosystemic shunt in cirrhotic patients with acute variceal bleeding: a systematic review and meta-analysis of controlled trials. European journal of gastroenterology & hepatology. 2015;27(9):e1-9.
dc.sourceMohamed R, Mitchell S. Acurracy of MELD score in predicting mortality in descompensated cirrosis from variceal bleeding, hepatorenal síndrome, alcoholic hepatitis ora cute liver failure as well as mortality after non-transplant surgery or TIPS. Diagnostic disease science. 2011 ; (56) 977-
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.subjectDerivación portosistemica trasnyugular (TIPS)
dc.subjectSangrado varicial
dc.subjectEncefalopatía hepática
dc.subjectReducción percutánea de flujo de TIPS
dc.subjectHipertensión portál
dc.subjectAscítis
dc.subjectCirrosis hepática
dc.titleExperiencia y porcentaje de complicaciones de las derivaciones portosistémicas intrahepáticas transyugulares en la Fundación Cardioinfantil
dc.typemasterThesis


Este ítem pertenece a la siguiente institución